Covariates | At time of SVI/B 2006–2015 | At time of study entry 2006–2015 | ||
Age at POAG-diagnosis | ||||
55–59 | 3 | 2.75% | 152 | 4.30% |
60–64 | 4 | 3.67% | 251 | 7.10% |
65–69 | 12 | 11.01% | 456 | 12.90% |
70–74 | 17 | 15.60% | 762 | 21.56% |
75–79 | 25 | 22.94% | 784 | 22.18% |
80–84 | 28 | 25.69% | 658 | 18.61% |
85–89 | 18 | 16.51% | 366 | 10.35% |
90+ | 2 | 1.83% | 106 | 3.00% |
Sex | ||||
Male | 35 | 32.11% | 1270 | 35.93% |
Female | 74 | 67.89% | 2265 | 64.07% |
Eye diseases (ever diagnosed after 2005) | ||||
Cataract | ||||
No | 6 | 5.50% | 543 | 15.36% |
Yes | 103 | 94.50% | 2992 | 84.64% |
Age-related macular degeneration | ||||
No | 46 | 42.20% | 2535 | 71.71% |
Yes | 63 | 57.80% | 1000 | 28.29% |
Disorders of optic nerve | ||||
No | 56 | 51.38% | 2364 | 66.87% |
Yes | 53 | 48.62% | 1171 | 33.13% |
Myopia | ||||
No | 66 | 60.55% | 2413 | 68.26% |
Yes | 43 | 39.45% | 1122 | 31.74% |
Retinopathy | ||||
No | 67 | 61.47% | 2393 | 67.69% |
Yes | 42 | 38.53% | 1142 | 32.31% |
Secondary glaucoma | ||||
No | 88 | 80.73% | 3347 | 94.68% |
Yes | 21 | 19.27% | 188 | 5.32% |
Retinal vascular occlusions | ||||
No | 88 | 80.73% | 3371 | 95.36% |
Yes | 21 | 19.27% | 164 | 4.64% |
Angle-closure glaucoma | ||||
No | 92 | 84.40% | 3301 | 93.38% |
Yes | 17 | 15.60% | 234 | 6.62% |
Injuries of the eye | ||||
No | 104 | 95.41% | 3440 | 97.31% |
Yes | 5 | 4.59% | 95 | 2.69% |
Ever diagnosed type 2 diabetes mellitus | ||||
No | 63 | 57.80% | 2047 | 57.91% |
Yes | 46 | 42.20% | 1488 | 42.09% |
Comorbidities | ||||
None | 3 | 2.75% | 347 | 9.82% |
1–2 | 26 | 23.85% | 1341 | 37.93% |
3–4 | 35 | 32.11% | 1020 | 28.85% |
5+ | 45 | 41.28% | 827 | 23.39% |
Year since POAG diagnosis | ||||
1st year | 22 | 20.18% | 3535 | 100.00% |
2nd year | 26 | 23.85% | 0 | 0.00% |
3rd–5th year | 46 | 42.20% | 0 | 0.00% |
6th–10th year | 15 | 13.76% | 0 | 0.00% |
Total | 109 | 100% | 3535 | 100% |
POAG, primary open-angle glaucoma; SVI/B, severe visual impairment and blindness.